跳至主要内容
临床试验/NCT01462981
NCT01462981Unknown不适用

Cohort of Hepatitis B Research of Amsterdam

Public Health Service of Amsterdam1 个研究点 分布在 1 个国家目标入组 172 人开始时间: 2011年9月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
172
试验地点
1

研究概览

简要总结

Hepatitis B is a form of liver disease caused by a DNA-virus, called hepatitis B virus (HBV). Infection can result in an inflammation of the liver parenchyma with various clinical manifestations ranging from an asymptomatic course to jaundice. After contact with the virus the immunological response of the host determines the clinical outcome leading to either viral clearance or a chronic infection.

Although several factors are responsible for the development of chronic HBV-infection, one of the factors is a weak and transient CD8+ T-cell responses after HBV infection. In chronic hepatitis B, inflammation can lead to scarring which is the driving force to fibrosis and cirrhosis. Some immunological parameters, like a newly discovered subset of IL-17 producing T helper cells (Th17 cells), may influence the disease progression of HBV. In the cirrhotic patient, eventually there is an increased risk of hepatocellular carcinoma (HCC) leading to liver failure.

Recent literature in Asian patients with chronic hepatitis B showed that serum HBV viral load is a strong predictor for the development of cirrhosis, independent of hepatitis B e- antigen status and serum alanine transaminase level. It is unclear whether these results can be extrapolated to non-Asian (Caucasian and African) populations because of differences in host (HLA background) and viral (HBV genotype) factors.

The aim of this study is to elucidate the question whether historic HBV viral load is associated with the risk of HBV-related cirrhosis or mortality in a cohort of non-Asian individuals with chronic hepatitis B infection.

详细描述

During one visit, the nurse will assess the quality of life of the included patients with the use of a health assessment questionnaire. This questionnaire is derived from a standardized questionnaire to assess the quality of life in patients, the SF-36. Participation will require a single visit to the outpatient clinic of Public Health Service. During this visit a short history and physical examination related to chronic liver disease will be performed. During the same visit a single venapunction and a single hepatic elastography (fibroscan) will be performed.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • HBsAg-positivity
  • Serum sample available from the screening programme at the Public Health Service
  • Still living and alive in Amsterdam or Diemen and address traceable by general practitioners or municipal authorities.
  • Non-Asian (both parents not born in Asia)
  • Between 18-65 years old
  • Capable of giving informed consent and capable of traveling to the Public Health Service

排除标准

  • Subjects coinfected with human immunodeficiency virus (HIV)
  • Subjects coinfected with hepatitis D virus (HDV)
  • Subjects coinfected with hepatitis C virus (HCV)
  • Subjects who are unable to come to the outpatient clinic
  • Subjects incapable to give informed consent due to legally incompetence

研究者

发起方
Public Health Service of Amsterdam
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

S. Harkisoen

MD

Public Health Service of Amsterdam

研究点 (1)

Loading locations...

相似试验